(Q34453402)

English

Efficacy and safety of alirocumab, a monoclonal antibody to PCSK9, in statin-intolerant patients: design and rationale of ODYSSEY ALTERNATIVE, a randomized phase 3 trial

scientific article

Statements

Efficacy and safety of alirocumab, a monoclonal antibody to PCSK9, in statin-intolerant patients: design and rationale of ODYSSEY ALTERNATIVE, a randomized phase 3 trial (English)
19 September 2014

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit